SCHEMBL14735869

SCHEMBL14735869

[V].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.92

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.92
CYP3A4 P08684 1/20 0.92
ESR1 P03372 4/20 0.63
ESR2 Q92731 4/20 0.63
KDM4E B2RXH2 1/20 0.48
GAA P10253 1/20 0.48
ALDH1A1 P00352 4/20 0.38
NPSR1 Q6W5P4 1/20 0.37
DRD1 P21728 2/20 0.35
TSHR P16473 4/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA9 Q16790 2/20 0.33
LMNA P02545 2/20 0.33
CA12 O43570 1/20 0.33
GLA P06280 1/20 0.33
CA3 P07451 1/20 0.33
CA4 P22748 1/20 0.33
CA14 Q9ULX7 1/20 0.33
ALOX12 P18054 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL6890099 0.96 TDP1 (1.00) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL5028587 0.96 TDP1 (1.00) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL2085135 0.96 TDP1 (1.00) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL101 0.96 TDP1 (1.00) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL25384985 0.92 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL22558063 0.92 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL480830 0.92 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL22445084 0.92 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL20582981 0.92 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL1195618 0.92 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233846-A1 INHIBITORS OF BROMODOMAINS Zenith Epigenetics Ltd. (CA) 2017-10-25 EP disclosed
WO-2016097863-A1 INHIBITORS OF BROMODOMAINS ZENITH EPIGENETICS CORP. (CA) 2016-06-23 WO disclosed
EP-2935253-A2 NOVEL HETEROCYCLIC COMPOUNDS AS BROMODOMAIN INHIBITORS Zenith Epigenetics Corp. (CA) 2015-10-28 EP disclosed
WO-2014096965-A2 NOVEL HETEROCYCLIC COMPOUNDS AS BROMODOMAIN INHIBITORS RVX THERAPEUTICS INC. (CA) 2014-06-26 WO disclosed
EP-2183232-B1 PI3 KINASE MODULATORS AND METHODS OF USE AMGEN INC (US) 2013-03-06 EP disclosed